Call Options

21 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Sep 21, 2023

SELL
$16.98 - $25.54 $127,350 - $191,550
-7,500 Reduced 4.7%
152,100 $2.85 Million
Q3 2022

Nov 14, 2022

SELL
$16.98 - $25.54 $127,350 - $191,550
-7,500 Reduced 4.7%
152,100 $2.85 Million
Q2 2022

Sep 21, 2023

SELL
$13.15 - $20.45 $351,105 - $546,015
-26,700 Reduced 14.33%
159,600 $2.97 Million
Q2 2022

Aug 15, 2022

SELL
$13.15 - $20.45 $351,105 - $546,015
-26,700 Reduced 14.33%
159,600 $2.98 Million
Q1 2022

Sep 21, 2023

SELL
$14.54 - $21.5 $2.06 Million - $3.05 Million
-141,700 Reduced 43.2%
186,300 $3.37 Million
Q1 2022

May 16, 2022

SELL
$14.54 - $21.5 $2.06 Million - $3.05 Million
-141,700 Reduced 43.2%
186,300 $3.37 Million
Q4 2021

Sep 21, 2023

BUY
$20.24 - $36.01 $552,552 - $983,073
27,300 Added 9.08%
328,000 $6.8 Million
Q4 2021

Feb 14, 2022

BUY
$20.24 - $36.01 $552,552 - $983,073
27,300 Added 9.08%
328,000 $6.8 Million
Q3 2021

Sep 21, 2023

BUY
$26.01 - $38.22 $5.74 Million - $8.44 Million
220,700 Added 275.88%
300,700 $9.63 Million
Q3 2021

Nov 15, 2021

BUY
$26.01 - $38.22 $5.74 Million - $8.44 Million
220,700 Added 275.88%
300,700 $9.63 Million
Q2 2021

Aug 20, 2021

SELL
$29.97 - $37.17 $237 Million - $294 Million
-7,920,000 Reduced 99.0%
80,000 $2.46 Million
Q2 2021

Aug 16, 2021

BUY
$29.97 - $37.17 $237 Million - $294 Million
7,920,000 Added 9900.0%
8,000,000 $2.46 Million
Q1 2021

Sep 21, 2023

BUY
$29.24 - $42.03 $508,776 - $731,322
17,400 Added 27.8%
80,000 $2.7 Million
Q1 2021

May 14, 2021

BUY
$29.24 - $42.03 $508,776 - $731,322
17,400 Added 27.8%
80,000 $2.7 Million
Q4 2020

Sep 21, 2023

SELL
$35.35 - $50.67 $3.16 Million - $4.53 Million
-89,500 Reduced 58.84%
62,600 $2.26 Million
Q4 2020

Feb 16, 2021

BUY
$35.35 - $50.67 $445,410 - $638,442
12,600 Added 25.2%
62,600 $2.26 Million
Q3 2020

Nov 13, 2020

BUY
$35.98 - $47.66 $1.8 Million - $2.38 Million
50,000 New
50,000 $1.84 Million
Q1 2020

May 15, 2020

SELL
$40.01 - $73.97 $1.2 Million - $2.22 Million
-30,000 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$37.13 - $74.62 $285,901 - $574,574
-7,700 Reduced 20.42%
30,000 $2.15 Million
Q3 2019

Nov 13, 2019

BUY
$39.36 - $76.8 $66,912 - $130,560
1,700 Added 4.72%
37,700 $1.48 Million
Q2 2019

Aug 14, 2019

BUY
$52.76 - $82.19 $1.9 Million - $2.96 Million
36,000 New
36,000 $2.81 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $280M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.